Cargando…

Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study

OBJECTIVE: We sought to evaluate the efficacy and tolerability of intranasal midazolam (in‐MDZ) as first‐line inhospital therapy in patients with status epilepticus (SE) during continuous EEG recording. METHODS: Data on medical history, etiology and semiology of SE, anticonvulsive medication usage,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kay, Lara, Merkel, Nina, von Blomberg, Anemone, Willems, Laurent M., Bauer, Sebastian, Reif, Philipp S., Schubert‐Bast, Susanne, Rosenow, Felix, Strzelczyk, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917318/ https://www.ncbi.nlm.nih.gov/pubmed/31682078 http://dx.doi.org/10.1002/acn3.50932

Ejemplares similares

Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring
por: von Blomberg, Anemone, et al.
Publicado: (2020)

Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes
por: Bauer, Kristina, et al.
Publicado: (2023)

Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures
por: Frey, Katharina, et al.
Publicado: (2020)

Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability
por: Kienitz, Ricardo, et al.
Publicado: (2022)

Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany
por: Purwien, Leonore, et al.
Publicado: (2023)

Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
por: Willems, Laurent M., et al.
Publicado: (2020)

Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review
por: Willems, Laurent M., et al.
Publicado: (2021)

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
por: Urban, Hans, et al.
Publicado: (2020)

Prospective evaluation of interrater agreement between EEG technologists and neurophysiologists
por: Beuchat, Isabelle, et al.
Publicado: (2021)

A comparison of intranasal ketamine and intranasal midazolam for pediatric premedication
por: Narendra, P. L., et al.
Publicado: (2015)

Cognitive Effects of Montelukast: A Pharmaco-EEG Study
por: Schwimmbeck, Fabian, et al.
Publicado: (2021)

The Winner by a Nose: Intranasal Midazolam
por: Faught, Edward
Publicado: (2019)

Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel‐Group Clinical Trial
por: Charalambous, M., et al.
Publicado: (2017)

Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi‐center randomized parallel group clinical study
por: Charalambous, Marios, et al.
Publicado: (2019)

Intranasal midazolam for rapid sedation of an agitated patient
por: Shrestha, Gentle Sunder, et al.
Publicado: (2015)

The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
por: Strzelczyk, Adam, et al.
Publicado: (2023)

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain
por: Strzelczyk, Adam, et al.
Publicado: (2019)

Intranasal Fentanyl, Midazolam and Dexmedetomidine as Premedication in Pediatric Patients
por: Chatrath, Veena, et al.
Publicado: (2018)

Comparative Study of Oral Midazolam Syrup and Intranasal Midazolam Spray for Sedative Premedication in Pediatric Surgeries
por: Mehdi, Imran, et al.
Publicado: (2019)

Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study
por: Willems, Laurent M., et al.
Publicado: (2018)

Intranasal Therapy to Stop Status Epilepticus in Prehospital Settings
por: Benfield, John, et al.
Publicado: (2017)

Comparison of preanesthetic sedation in pediatric patients with oral and intranasal midazolam
por: Deshmukh, Purvashree Vijay, et al.
Publicado: (2016)

Efficacy of intranasal dexmedetomidine versus oral midazolam for paediatric premedication
por: Kumar, Lakshmi, et al.
Publicado: (2017)

High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors
por: Brauchitsch, Sophie von, et al.
Publicado: (2022)

Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case–Control Analysis from Germany
por: Kortland, Lena-Marie, et al.
Publicado: (2017)

Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
por: Cossovel, Francesca, et al.
Publicado: (2022)

Dravet syndrome: A systematic literature review of the illness burden
por: Strzelczyk, Adam, et al.
Publicado: (2023)

Comparison of Intranasal Dexmedetomidine and Oral Ketamine Versus Intranasal Midazolam Premedication for Children Undergoing Dental Rehabilitation
por: Oriby, Mohamed E
Publicado: (2019)

Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate‐induced status epilepticus in rats
por: Dhir, Ashish, et al.
Publicado: (2020)

Intranasal Midazolam May Prevent Gagging Reflex: a Case Report
por: Malkoc, Meral Arslan, et al.
Publicado: (2013)

Safety and effectiveness of intranasal dexmedetomidine together with midazolam for sedation in neonatal MRI
por: Inserra, Emanuela, et al.
Publicado: (2021)

Randomized clinical trial on the efficacy of intranasal or oral ketamine-midazolam combinations compared to oral midazolam for outpatient pediatric sedation
por: Sado-Filho, Joji, et al.
Publicado: (2019)

Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies
por: Strzelczyk, Adam, et al.
Publicado: (2021)

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
por: Schubert-Bast, Susanne, et al.
Publicado: (2021)

A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
por: Strzelczyk, Adam, et al.
Publicado: (2022)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

DIagnostic Subdural EEG electrodes And Subdural hEmatoma (DISEASE): a study protocol for a prospective nonrandomized controlled trial
por: Won, Sae-Yeon, et al.
Publicado: (2020)

Recurrent Metabolic Acidosis during High-dose Midazolam Therapy for Refractory Status Epilepticus
por: Singh, Shalendra, et al.
Publicado: (2018)

Soman‐induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam
por: Marrero‐Rosado, Brenda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rto9qrdu9r1jcce4eup750mjh8